Both in Pharmaceuticals
Alto Neuroscience vs Savara
Over the past year ANRO returned +562.8% and SVRA returned +44.3%; their daily moves had a correlation of 0.28.
ANRO +562.8% SVRA +44.3%Growth of $1, one year, split-adjusted
| Metric | ANRO | SVRA |
|---|---|---|
| Price | $26.58 | $5.08 |
| Market cap | $1.04B | $1.04B |
| Today | −0.30% | +0.20% |
| 1 month | −24.3% | −3.4% |
| 6 months | +33.0% | +0.6% |
| Year to date | +49.3% | −15.8% |
| 1 year | +572.9% | +44.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $225.1M | $142.9M |
| Dividend yield | — | — |
| Volatility (60d) | 55.6% | 44.0% |
| Short % of float | 16.0% | 30.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).